Your browser doesn't support javascript.
loading
Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy.
Altman, Matthew C; Segnitz, R Max; Larson, David; Jayavelu, Naresh Doni; Smith, Malisa T; Patel, Sana; Scadding, Guy W; Qin, Tielin; Sanda, Srinath; Steveling, Esther; Eifan, Aarif O; Penagos, Martin; Jacobson, Mikila R; Parkin, Rebecca V; Shamji, Mohamed H; Togias, Alkis; Durham, Stephen R.
Affiliation
  • Altman MC; Systems Immunology Division, Benaroya Research Institute, Seattle; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle. Electronic address: maltman@benaroyaresearch.org.
  • Segnitz RM; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle.
  • Larson D; Immune Tolerance Network, Bethesda.
  • Jayavelu ND; Systems Immunology Division, Benaroya Research Institute, Seattle.
  • Smith MT; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle.
  • Patel S; Division of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle.
  • Scadding GW; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Qin T; Immune Tolerance Network, Bethesda.
  • Sanda S; Madison Clinic for Pediatric Diabetes, University of California San Francisco, San Francisco.
  • Steveling E; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Eifan AO; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Penagos M; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Jacobson MR; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Parkin RV; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Shamji MH; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
  • Togias A; The National Institute of Allergy and Infectious Disease, Bethesda.
  • Durham SR; Immunomodulation and Tolerance Group, Allergy and Clinical Immunology, Department of National Heart and Lung Institute, London.
J Allergy Clin Immunol ; 152(5): 1247-1260, 2023 11.
Article in En | MEDLINE | ID: mdl-37460024

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sublingual Immunotherapy / Rhinitis, Allergic Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sublingual Immunotherapy / Rhinitis, Allergic Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2023 Type: Article